This inventor holds 17 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Dermatological Treatments. Top assignees: Amderma Pharmaceuticals, LLC, Action Medicines, S.l., Other. Active years: 2011-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2019
Areas of Expertise:
Title: **Antonio Romero Garrido: Innovator in Dermatological Treatments**
Introduction
Antonio Romero Garrido, based in Madrid, Spain, is a prominent inventor known for his significant contributions to the field of dermatology. With an impressive portfolio of 17 patents, Garrido has focused much of his research on developing innovative treatments for skin conditions.
Latest Patents
Among his latest inventions are two notable patents centered around the therapeutic applications of 2,5-dihydroxybenzene derivatives. The first patent pertains to the use of these compounds for treating dermatitis, where he outlines the therapeutic and prophylactic benefits of using a 2,5-dihydroxybenzene derivative for combating this common skin ailment. The second patent further expands on this by exploring the use of 2,5-dihydroxybenzene compounds specifically for the treatment of skin cancer, highlighting his dedication to tackling severe dermatological issues.
Career Highlights
Garrido has worked with reputable companies such as Amderma Pharmaceuticals, LLC and Action Medicines, S.L., where he has played a pivotal role in research and development. His efforts in these organizations have propelled advancements in dermatological treatments, underscoring his commitment to improving patient outcomes.
Collaborations
Throughout his career, Garrido has collaborated with notable colleagues, including Guillermo Gimenez Gallego and Serafin Valverde Lopez. These partnerships have enabled him to leverage diverse expertise and insights, contributing to the success of his inventions and patents.
Conclusion
Antonio Romero Garrido stands out as a key figure in skin health innovations. His extensive work with 2,5-dihydroxybenzene derivatives demonstrates his commitment to addressing critical dermatological challenges. As he continues to innovate, the impact of his patents will undoubtedly extend to improving treatments for skin disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile